|Articles|June 1, 2007

Common Hospital Device Could Lead to Patient Infections

Patients might be at greater risk for developing bloodstream infections due to a common device used in hospitals around the country, according to a research team at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska. The device is a needleless intravascular catheter connector valve, commonly used for hospital patients with a vascular catheter in place. Vascular catheters are widely used in many types of patients for the infusion of medications, blood products or fluids, and the connector valve is the small piece of equipment that connects the catheter to the IV tubing.

The first generation of needleless devices was introduced into medical care over a decade ago in order to prevent needlestick injuries and bloodborne pathogen exposure in healthcare workers. More recently, mechanical valves have been incorporated into the devices in an attempt to minimize the risk of catheter occlusion. Unfortunately, some of these devices may be putting patients in harms way, said Mark Rupp, MD, who commented, It really points out that even seemingly small changes in vascular access devices can have devastating unintended consequences, and how careful we need to be when peoples lives are at stake.

Rupp is an infectious diseases specialist at UNMC and The Nebraska Medical Center, and the principal investigator on the study. His teams findings were reported in the June 1 issue of the journal Clinical Infectious Diseases.

The particular needleless connector valve in the study was introduced into clinical use in February 2005 at the Nebraska Medical Center, but later completely removed from clinical use when evidence associated the valve with an increased rate of bloodstream infection. Bloodstream infections are quite serious and can result in mortality or prolonged hospital stay.

The UNMC research team is one of the first groups in the country to note this trend. They initially presented their findings to the scientific medical community in the spring of 2006.

In performing blood cultures on patients hospitalized during the study period, the researchers determined that ICU patients with the needle-less connector valve experienced bloodstream infections at nearly three times the rate compared to the time period before the valve was used. In regular inpatient nursing units, the bloodstream infection rate more than doubled when the needle-less connector valves were in use.

With the needleless connector valves, bloodstream infections in ICU patients increased from 3.87 infections per 1,000 catheter days to 10.64 infections per 1,000. In inpatient nursing units, the introduction of the connector valves resulted in an increase of bloodstream infections from 3.47 infections per 1,000 catheter days to 7.3 infections per 1,000. Since discontinuing the use of needle-less connector valves, Rupp noted that the bloodstream infection rate at the Nebraska Medical Center has returned to the accepted national benchmark level.

Every hospital in the country is using similar types of devices, Rupp said. We felt it incumbent upon ourselves to report our study results in a scientific journal. In addition, we notified the Food and Drug Administration (FDA) and the manufacturer.

Rupp said similar needleless connector valves are produced by at least six different manufacturers. Many of these devices are being introduced into the healthcare arena without undergoing rigorous testing in clinical settings, he said. Hospitals and doctors need to be aware of the increased risks potentially involved with using some of these devices.

Rupp said the valves have a shallow depression and rim. Its possible that microbes and debris could collect in this depression, making them relatively resistant to cleansing or disinfectants, he said. They also are opaque, making it more difficult for health care workers to observe if blood or infusion products are collecting within the valve.

Once the higher rate of bloodstream infections was determined, Rupp said the hospital immediately stopped using the mechanical needle-less connector valves and went back to using the older version.

Source: University of Nebraska Medical Center


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.